Abstract:Objective: To evaluate the effect of ultraviolet A/riboflavin corneal crosslinking (CXL) on keratoconic patients with a corneal thickness less than 400 μm. Methods: In this prospective study, patients with keratoconus were divided into a thin cornea group with a corneal thickness (CT) less than 400 μm and a thick cornea group with a CT more than 400 μm. The patients in the thin and thick cornea groups were treated with a hypotonic or isotonic riboflavin solution before and during CXL. Corneal morphological parameters were evaluated before and after CXL during a 3-year follow-up. The data were analyzed with a repeated measures ANOVA, t test, Wilcoxon rank sum test or Mann-Whitney U test. Results: After surgery, the maximum keratometry (Kmax) of the thin and thick cornea groups underwent a continuous decrease (F= 24.364, P<0.001; F=10.427, P=0.001). In the thin group, the Kmax value was 60.51±6.11 diopters (D) before surgery and significantly decreased to 57.43±6.82 D, 56.13±6.85 D and 54.97±6.66 D at 1, 2 and 3 years after surgery (t=3.670, P=0.002; t=4.637, P<0.001; t=5.816, P<0.001). In the thick group, the Kmax value was 54.56±6.27 D before surgery and significantly decreased to 53.25±6.42 D, 52.32±6.47 D and 51.58±6.70 D at 1, 2 and 3 years after surgery (t=2.266, P=0.040; t=3.302, P=0.005; t=3.769, P=0.002). The Kmax value of the thin cornea group before surgery was higher than that of the thick cornea group (t=2.714, P=0.011). There were no significant differences in Kmax between the two groups at 1 year, 2 years or 3 years. In the thin group, there were significant differences between the preoperative and 3-year postoperative visual acuity (UCVA), best corrected visual acuity (BCVA) and thinnest corneal thickness (TCT) (Z=-2.716, P=0.007; Z=-3.063, P=0.002; t=4.468, P<0.001). In the thick group, there were significant differences between the preoperative and 3-year postoperative UCVA, BCVA and TCT (t=3.572, P=0.003; Z=-2.956, P=0.003; Z=-3.410, P=0.001). In the two groups, there were no significant differences between the preoperative and 3-year postoperative intraocular pressure (IOP) or endothelial cell density (ECD). There were no significant differences in pre- or postoperative UCVA, BCVA, IOP, or ECD between the two groups. There were significiant differences in pre- and postoperative TCT between the two groups (Z=-4.816, P=0.001; Z=-4.024, P<0.001). Conclusion: CXL is an effective and safe way to halt disease progression and improve visual acuity in keratoconic patients with a CT less than 400 μm.

Changes in retinal vessel and retinal layer thickness after cross-linking in keratoconus via swept-source OCT angiography

Comparison of Deep Anterior Lamellar Keratoplasty and Corneal Cross-Linking in Patients with Advanced Keratoconus.

Detecting early changes in choroidal vascularity and thickness using optical coherence tomography in patients with corneal crosslinking for keratoconus

Does collagen cross linking have any effect on retinal circulation in patients with keratoconus? An optical coherence tomography angiography (OCTA) study

One-year Outcomes of Pachymetry and Epithelium Thicknesses after Accelerated (45 Mw/cm2) Transepithelial Corneal Collagen Cross-linking for Keratoconus Patients

Accelerated (45 Mw/cm2) Transepithelial Corneal Cross-Linking for Progressive Keratoconus Patients: Long-Term Topographical and Clinical Outcomes.

Corneal biomechanical outcome of collagen cross-linking in keratoconic patients evaluated by Corvis ST

Long-term changes in crystalline lens transparency after accelerated transepithelial corneal cross-linking in patients with keratoconus

The Evaluation of Ultraviolet A/Riboflavin Corneal Crosslinking on Keratoconic Patients with a Corneal Thickness Less than 400 μm:A 3-Year Follow-Up

Long-term study of topographic changes following pulsed accelerated corneal collagen cross-linking in progressive keratoconus

Corneal Collagen Cross-Linking with Hypoosmolar Riboflavin Solution in Keratoconic Corneas

Systematic Review and Meta-analysis Comparing Modified Cross-Linking and Standard Cross-Linking for Progressive Keratoconus.

134: THE EFFECTIVENESS OF CXL IN THE TREATMENT OF KERATOCONUS

Clinical and Morphological in Vivo Confocal Microscopy Findings following a Modified Biphasic Higher Fluence Transepithelial Corneal Crosslinking

Topography-guided Corneal Surface Laser Ablation Combined with Simultaneous Accelerated Corneal Collagen Cross-Linking for Treatment of Keratoconus

Conventional and Transepithelial Corneal Cross-Linking for Patients with Keratoconus.

Changes in corneal biomechanical parameters in keratoconus eyes with various severities after corneal cross-linking (CXL): A comparative study

Comparative Evaluation of Anterior Segment Optical Coherence Tomography Findings Following Accelerated Corneal Crosslinking Protocols Using Different Riboflavin Formulations and Soaking Durations

Three-year Clinical Observation of the Outcomes of Transepithelial and Epithelial-off Accelerated Corneal Collagen Crosslinking Treatment for Different Types of Progressive Keratoconus.

Epithelial Remodelling After Epithelium-off Continuous Accelerated Corneal Collagen Cross-linking in Progressive Keratoconus

One-Year Follow-Up of Changes in Corneal Densitometry after Accelerated (45 Mw/Cm(2)) Transepithelial Corneal Collagen Cross-Linking for Keratoconus: A Retrospective Study